Biogen says Aduhelm lowers levels of second protein associated with Alzheimer’s, Health News, ET HealthWorld
By Deena Beasley – Biogen Inc’s Alzheimer’s drug Aduhelm, approved by U.S. regulators last year for its ability to reduce amyloid brain plaques, also lowers levels of a second protein…

